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Background
The I313V mutation of the NLRP3 gene has been only
anecdotally reported and described in association with
the so-called Magic Syndrome (Infevers database). How-
ever, nor the clinical or pathophysiological significance
of such mutation has been so far reported.
Aim
To describe the clinical picture of patients carrying the
I313V mutation and its consequences in IL-1b secretion.
Methods
Two families carrying NLRP3 I313V mutation were
evaluated. Monocytes were obtained from patients and
their parents. Cells isolated from healthy donors (HD)
(N=14) were used as negative control group. Pattern of
secretion of IL-1b, IL-1Ra, IL-6 and IL-8 were then
assessed by ELlSA in the presence or absence exogenous
LPS.
Results
Both case #1 (M.T) and #2 (V.C) displayed a mild clini-
cal phenotype (episodes of urticarial rash and arthralgia
associated with elevation of acute phase reactants), com-
patible with FCAS and Muckle-Wells syndrome, respec-
tively. Both patients displayed good response to NSAID
and/or steroid on demand. Compared to HD controls,
patients displayed enhanced and delayed IL1b secretion.
This was accompanied by higher levels of lL1Ra and
IL-6 without any significant differences in IL-8. Interest-
ingly, parents carrying the mutation also displayed
higher levels of secreted IL-1b compared to HD control
group.
Conclusion
The I313V mutation is associated with a mild CAPS
phenotype and with an increased IL-1b secretion.
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